The investment objective of the scheme is to provide returns before expenses that closely correspond to the total returns of the Nifty Alpha Low Volatility 30 Index, subject to tracking errors.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -5.28% | -7.44% | -4.25% | -8.15% | -9% | -8.97% | N/A | N/A | N/A | N/A | -3.5% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.22% | N/A |
| Absolute returns | -5.28% | -7.44% | -4.25% | -8.15% | -9% | -17.16% | N/A | N/A | N/A | N/A | -8.29% |
| Rank within category | 167/216 | 190/207 | 138/199 | 158/193 | 145/184 | 97/116 | N/A | N/A | N/A | N/A | N/A |
| Index Funds | 2024 | 2025 | 2026 |
|---|---|---|---|
| Yearly returns | N/A | -1.08% | -8.75% |
| Q1 returns | N/A | -7.87% | -11.69% |
| Q2 returns | N/A | 7.99% | 9.58% |
| Q3 returns | 11.02% | -4.42% | -3.87% |
| Q4 returns | -12.61% | 4.02% | -1.9% |
0.10% on or before 15D, Nil after 15D
| Alpha | -0.110891 |
| Beta | 0.998 |
| Sharpe Ratio | -0.160589 |
| Sortino Ratio | -0.239209 |
| R-Squared | 0.9962 |
| Tracking Error | 0.0814 |
| Downside Risk | 23.4876 |
| Std. Deviation (Annualised) | 14.1348 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.22 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| Edelweiss Nifty Alpha Low Volatility 30 Index Fund - Regular Plan - Growth Current | -5.28% | -7.44% | -4.25% | -8.15% | -9% | N/A | N/A | N/A | -3.5% | 79.89 | 1.31 | -0.16 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.73% |
| NTPC Ltd. | Power | Domestic Equities | 4.11% |
| Bajaj Auto Ltd. | Automobiles | Domestic Equities | 4.01% |
| Marico Ltd. | Agricultural Food & other Products | Domestic Equities | 3.99% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 3.93% |
| Hindalco Industries Ltd. | Non - Ferrous Metals | Domestic Equities | 3.81% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 3.78% |
| Nestle India Ltd. | Food Products | Domestic Equities | 3.72% |
| JSW Steel Ltd. | Ferrous Metals | Domestic Equities | 3.62% |
| Grasim Industries Ltd. | Cement & Cement Products | Domestic Equities | 3.61% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.61% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 3.54% |
| SBI Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.53% |
| Cummins India Ltd. | Industrial Products | Domestic Equities | 3.49% |
| Bharti Airtel Ltd. | Telecom - Services | Domestic Equities | 3.33% |
| Titan Company Ltd. | Consumer Durables | Domestic Equities | 3.26% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.24% |
| TVS Motor Company Ltd. | Automobiles | Domestic Equities | 3.23% |
| State Bank Of India | Banks | Domestic Equities | 3.14% |
| Pidilite Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 3.06% |
| Coal India Ltd. | Consumable Fuels | Domestic Equities | 3.05% |
| Eicher Motors Ltd. | Automobiles | Domestic Equities | 3.03% |
| Britannia Industries Ltd. | Food Products | Domestic Equities | 2.91% |
| Reliance Industries Ltd. | Petroleum Products | Domestic Equities | 2.82% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.79% |
| Ultratech Cement Ltd. | Cement & Cement Products | Domestic Equities | 2.75% |
| Asian Paints Ltd. | Consumer Durables | Domestic Equities | 2.72% |
| Maruti Suzuki India Ltd. | Automobiles | Domestic Equities | 2.51% |
| Tata Consumer Products Ltd. | Agricultural Food & other Products | Domestic Equities | 2.49% |
| Max Financial Services Ltd. | Insurance | Domestic Equities | 2.19% |
| Clearing Corporation of India Ltd. | Cash & Cash Equivalents and Net Assets | 0.06% | |
| Accrued Interest | Cash & Cash Equivalents and Net Assets | 0.00% | |
| Net Receivables/(Payables) | Cash & Cash Equivalents and Net Assets | -0.06% | |
| Total | 100.00% | ||
Ms. Manasi Subhash Jalgaonkar joined Edelweiss Asset Management Company in April 2022 as Assistant Fund Manager.She works closely with fund managers to deliver investment insights, with responsibilities spanning fund attribution, peer analysis, IPO research support, compliance coordination, index fund rebalancing, and proxy voting. Prior to this, she was associated with ICICI Prudential AMC, PGIM Mutual Fund, and CMC Ltd., where she gained extensive experience in investment operations, compliance, data management, and cross-functional coordination.She was recognized with a Motilal Oswal award in 2025 for her contributions to the research industry.
Get personalized portfolio management services designed to grow and protect your wealth.